<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Nucl Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Nucl Med</journal-id>
      <journal-id journal-id-type="publisher-id">RLU</journal-id>
      <journal-title-group>
        <journal-title>Clinical Nuclear Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0363-9762</issn>
      <issn pub-type="epub">1536-0229</issn>
      <publisher>
        <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26975011</article-id>
      <article-id pub-id-type="pmc">4859201</article-id>
      <article-id pub-id-type="publisher-id">RLU50416</article-id>
      <article-id pub-id-type="doi">10.1097/RLU.0000000000001202</article-id>
      <article-id pub-id-type="art-access-id">00015</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Interesting Images</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea</article-title>
        <subtitle>Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sato</surname>
            <given-names>Kenichiro</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hida</surname>
            <given-names>Ayumi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kameyama</surname>
            <given-names>Masashi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morooka</surname>
            <given-names>Miyako</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takeuchi</surname>
            <given-names>Sousuke</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">From the *Department of Neurology, and &#x2020;Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.</aff>
      <author-notes>
        <corresp id="cor1">Correspondence to Ayumi Hida, MD, PhD, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan. E-mail: <email>ayumi-hida@umin.ac.jp</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <volume>41</volume>
      <issue>6</issue>
      <fpage>481</fpage>
      <lpage>482</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <copyright-holder>Wolters Kluwer Health, Inc. All rights reserved.</copyright-holder>
        <license>
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</ext-link>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.</license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="rlu-41-481.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>We report a 64-year-old man with diabetic chorea whom we investigated with dopamine transporter SPECT, <sup>18</sup>F FDG PET, <sup>99m</sup>Tc ethylcysteinate dimer (ECD) SPECT, and <sup>123</sup>I metaiodobenzylguanidine (MIBG) scintigraphy. Dopamine transporter SPECT revealed reduced <sup>123</sup>I ioflupane binding in the bilateral striatum. <sup>18</sup>F FDG PET showed metabolic dysfunction in the bilateral striatum, as shown in earlier studies. <sup>99m</sup>Tc ECD SPECT revealed reduced brain perfusion in the bilateral caudate nucleus and putamen. <sup>123</sup>I MIBG scintigraphy revealed no cardiac sympathetic nerve dysfunction. Our case suggests a possible nigrostriatal presynaptic dopaminergic involvement in diabetic chorea.</p>
      </abstract>
      <kwd-group>
        <title>Key Words</title>
        <kwd>diabetic chorea</kwd>
        <kwd><sup>123</sup>I ioflupane</kwd>
        <kwd>dopamine transporter SPECT</kwd>
        <kwd><sup>18</sup>F FDG PET</kwd>
        <kwd><sup>123</sup>I MIBG scintigraphy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <fig id="FU1" position="float">
      <label>FIGURE 1</label>
      <caption>
        <p>We present a 64-year-old man with subacute left-side dominant bilateral choreic movement (diabetic chorea) evaluated using a combination of dopamine transporter SPECT, <sup>18</sup>F FDG PET, <sup>99m</sup>Tc ethylcysteinate dimer (<sup>99m</sup>Tc ECD) SPECT, and <sup>123</sup>I metaiodobenzylguanidine (MIBG) scintigraphy. We diagnosed him with diabetic chorea because of poorly controlled diabetes mellitus (HbA1c 13%-18%) and brain MRI showing pathognomonic hyperintensity on T1-weighted imaging in the bilateral caudate nucleus and putamen and right-side external segment of the globus pallidus (<bold>A</bold>). No significant abnormality on T2- (<bold>B</bold>) and T2*-weighted images (<bold>C</bold>) was found in the corresponding area. No significant old infarction or other differential diagnoses for chorea were identified.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Dopamine transporter SPECT showed bilaterally and right-side dominant reduced <sup>123</sup>I ioflupane binding in the caudate nucleus and putamen (<bold>D</bold>). The specific binding ratio<sup><xref rid="R2" ref-type="bibr">2</xref></sup> was 1.22 on the right and 1.36 on the left side (ELEGP was used as a collimator, and no scatter correction or attenuation correction was applied). The asymmetry dopamine transporter SPECT in diabetic chorea index (AI) of ioflupane binding was 10.7%, revealing a decline predominantly on the right side. This was consistent with the contralateral dominance of the chorea. No confounding medication for the evaluation with dopamine transporter SPECT was identified.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Brain <sup>18</sup>F FDG PET revealed decreased glucose metabolism (<bold>E</bold>) in the corresponding area, similar to the dopamine transporter SPECT, suggesting regional dysfunction in the bilateral striatum. There was no significant left-to-right difference in striatal <sup>18</sup>F FDG PET uptake, with an AI of 2.7%. <sup>99m</sup>Tc ECD SPECT revealed reduced brain perfusion in the bilateral caudate nucleus, putamen, and thalamus (<bold>F</bold>). <sup>123</sup>I MIBG scintigraphy showed no reduction in the H/M ratio, with 4.95 in the early phase and 5.03 in the late phase (<bold>G</bold>, late phase). We assumed that a low accumulation in the mediastinum caused this high H/M ratio. Treatment with dopamine antagonist and blood glucose control relieved most choreic symptoms within 4 weeks, and we are now successfully reducing his dopamine antagonist dose. Reduced glucose metabolism was found in the bilateral putamen and caudate nucleus in the <sup>18</sup>F FDG PET in our patient, suggesting regional striatal dysfunction. This was consistent with earlier studies on diabetic chorea.<sup><xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R7" ref-type="bibr">7</xref></sup> Several theories regarding the underlying pathology of diabetic chorea have been proposed, including petechial hemorrhage,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> metabolic abnormality because of hyperglycemia,<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> patchy striatal necrosis associated with vasculopathy,<sup><xref rid="R6" ref-type="bibr">6</xref></sup> and transient ischemia.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> No conclusion has been reached to date. The only earlier report using dopamine transporter SPECT with hyperglycemic hemichorea-hemiballismus<sup><xref rid="R8" ref-type="bibr">8</xref></sup> revealed decreased <sup>123</sup>I ioflupane binding in the striatum as was observed in our case. Cardiac imaging with <sup>123</sup>I MIBG scintigraphy in our case revealed normal <sup>123</sup>I MIBG uptake by the cardiac sympathetic nerve, suggesting that coexisting Parkinson&#x2019;s disease, Lewy body disease, diabetic sympathetic nerve dysfunction, or heart failure were unlikely. This suggests nigrostriatal dopaminergic involvement: presynaptic neuronal terminal dysfunction, reduced density of nerve terminals, or reduced density of dopamine transporter is conceivable.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref></sup></p>
      </caption>
      <graphic xlink:href="rlu-41-481-g001"/>
    </fig>
  </body>
  <back>
    <fn-group>
      <fn id="fn2">
        <p>Conflicts of interest and sources of funding: This study is supported by a grant from the National Center for Global Health and Medicine (to M.K.).</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Cardoso</surname><given-names>F</given-names></name><name><surname>Seppi</surname><given-names>K</given-names></name><name><surname>Mair</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Seminar on choreas</article-title>. 
<source><italic>Lancet Neurol</italic></source>. 
<year>2006</year>;
<volume>5</volume>:
<fpage>589</fpage>&#x2013;
<lpage>602</lpage>.<pub-id pub-id-type="pmid">16781989</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Tossici-Bolt</surname><given-names>L</given-names></name><name><surname>Hoffmann</surname><given-names>SM</given-names></name><name><surname>Kemp</surname><given-names>PM</given-names></name><etal/></person-group>
<article-title>Quantification of [<sup>123</sup>I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio</article-title>. 
<source><italic>Eur J Nucl Med Mol Imaging</italic></source>. 
<year>2006</year>;
<volume>33</volume>:
<fpage>1491</fpage>&#x2013;
<lpage>1499</lpage>.<pub-id pub-id-type="pmid">16858570</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>K&#xE4;gi</surname><given-names>G</given-names></name><name><surname>Bhatia</surname><given-names>KP</given-names></name><name><surname>Tolosa</surname><given-names>E</given-names></name></person-group>
<article-title>The role of DAT-SPECT in movement disorders</article-title>. 
<source><italic>J Neurol Neurosurg Psychiatry</italic></source>. 
<year>2010</year>;
<volume>81</volume>:
<fpage>5</fpage>&#x2013;
<lpage>12</lpage>.<pub-id pub-id-type="pmid">20019219</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Hosokawa</surname><given-names>S</given-names></name><name><surname>Ichiya</surname><given-names>Y</given-names></name><name><surname>Kuwabara</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Positron emission tomography in cases of chorea with different underlying diseases</article-title>. 
<source><italic>J Neurol Neurosurg Psychiatry</italic></source>. 
<year>1987</year>;
<volume>50</volume>:
<fpage>1284</fpage>&#x2013;
<lpage>1287</lpage>.<pub-id pub-id-type="pmid">2960785</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Hsu</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>HC</given-names></name><name><surname>Hsu</surname><given-names>WC</given-names></name></person-group>
<article-title>Hyperglycemia-induced unilateral basal ganglion lesions with and without hemichorea. A PET study</article-title>. 
<source><italic>J Neurol</italic></source>. 
<year>2004</year>;
<volume>251</volume>:
<fpage>1486</fpage>&#x2013;
<lpage>1490</lpage>.<pub-id pub-id-type="pmid">15645348</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Soeda</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Diabetic striatal disease: clinical presentation, neuroimaging, and pathology</article-title>. 
<source><italic>Intern Med</italic></source>. 
<year>2009</year>;
<volume>48</volume>:
<fpage>1135</fpage>&#x2013;
<lpage>1141</lpage>.<pub-id pub-id-type="pmid">19571446</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Im</surname><given-names>JH</given-names></name><etal/></person-group>
<article-title>Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases</article-title>. 
<source><italic>J Neurol Sci</italic></source>. 
<year>2002</year>;
<volume>200</volume>:
<fpage>57</fpage>&#x2013;
<lpage>62</lpage>.<pub-id pub-id-type="pmid">12127677</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Belcastro</surname><given-names>V</given-names></name><name><surname>Pierguidi</surname><given-names>L</given-names></name><name><surname>Tambasco</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Decreased contralateral putamen [<sup>123</sup>I]FP-CIT SPECT uptake in hyperglycemic hemichorea-hemiballismus</article-title>. 
<source><italic>Eur Neurol</italic></source>. 
<year>2011</year>;
<volume>65</volume>:
<fpage>307</fpage>&#x2013;
<lpage>308</lpage>.<pub-id pub-id-type="pmid">21576966</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group><name><surname>Booth</surname><given-names>TC</given-names></name><name><surname>Nathan</surname><given-names>M</given-names></name><name><surname>Waldman</surname><given-names>AD</given-names></name><etal/></person-group>
<article-title>The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2</article-title>. 
<source><italic>AJNR Am J Neuroradiol</italic></source>. 
<year>2015</year>;
<volume>36</volume>:
<fpage>236</fpage>&#x2013;
<lpage>244</lpage>.<pub-id pub-id-type="pmid">24924549</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
